SEC Form 8-K Summary
Registrant: Blue Water Vaccines Inc. (the request metadata identifies Onconetix, Inc.; the filing itself identifies Blue Water Vaccines Inc.)
Reporting date: April 20, 2022. The filing reports an event under Item 7.01, Regulation FD Disclosure.
Business Context and Event
The company furnished a presentation as Exhibit 99.1 for meetings and presentations at the World Vaccine Congress 2022 in Washington, D.C., held on April 20, 2022.
The filing states that the presentation was furnished, not filed, and is not subject to liability under Section 18 of the Exchange Act or incorporated by reference into other filings.
Financial Metrics and Liquidity
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes Versus Prior Period
The filing does not report financial or operational changes versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, financial outlook, management forecasts, risk updates, contingencies, or unusual accounting items. The underlying presentation content is not included in the supplied filing text.
Important Facts to Verify
- Verify the registrant identity: the filing names Blue Water Vaccines Inc., while the request metadata names Onconetix, Inc.
- Review Exhibit 99.1 directly for the scientific, business, or strategic information presented at the World Vaccine Congress.
- Confirm that the presentation was furnished under Regulation FD and was not filed for purposes of Section 18 liability.
- Consult the company’s periodic financial filings for financial performance, cash runway, debt, liquidity, and risk information.